These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 38224248)
1. Decoding the DNA methylome of central nervous system tumors: An emerging modality for integrated diagnosis. Satomi K; Ichimura K; Shibahara J Pathol Int; 2024 Feb; 74(2):51-67. PubMed ID: 38224248 [TBL] [Abstract][Full Text] [Related]
2. Validation of Whole Genome Methylation Profiling Classifier for Central Nervous System Tumors. Santana-Santos L; Kam KL; Dittmann D; De Vito S; McCord M; Jamshidi P; Fowler H; Wang X; Aalsburg AM; Brat DJ; Horbinski C; Jennings LJ J Mol Diagn; 2022 Aug; 24(8):924-934. PubMed ID: 35605901 [TBL] [Abstract][Full Text] [Related]
3. Diagnostic DNA methylome profiling and the WHO 5 Frank S; Hench J Clin Neuropathol; 2022; 41(4):153-156. PubMed ID: 35670246 [TBL] [Abstract][Full Text] [Related]
4. The central nervous system tumor methylation classifier changes neuro-oncology practice for challenging brain tumor diagnoses and directly impacts patient care. Karimi S; Zuccato JA; Mamatjan Y; Mansouri S; Suppiah S; Nassiri F; Diamandis P; Munoz DG; Aldape KD; Zadeh G Clin Epigenetics; 2019 Dec; 11(1):185. PubMed ID: 31806041 [TBL] [Abstract][Full Text] [Related]
5. Impact of the methylation classifier and ancillary methods on CNS tumor diagnostics. Wu Z; Abdullaev Z; Pratt D; Chung HJ; Skarshaug S; Zgonc V; Perry C; Pack S; Saidkhodjaeva L; Nagaraj S; Tyagi M; Gangalapudi V; Valdez K; Turakulov R; Xi L; Raffeld M; Papanicolau-Sengos A; O'Donnell K; Newford M; Gilbert MR; Sahm F; Suwala AK; von Deimling A; Mamatjan Y; Karimi S; Nassiri F; Zadeh G; Ruppin E; Quezado M; Aldape K Neuro Oncol; 2022 Apr; 24(4):571-581. PubMed ID: 34555175 [TBL] [Abstract][Full Text] [Related]
6. DNA methylation-based profiling of bone and soft tissue tumours: a validation study of the 'DKFZ Sarcoma Classifier'. Lyskjaer I; De Noon S; Tirabosco R; Rocha AM; Lindsay D; Amary F; Ye H; Schrimpf D; Stichel D; Sill M; Koelsche C; Pillay N; Von Deimling A; Beck S; Flanagan AM J Pathol Clin Res; 2021 Jul; 7(4):350-360. PubMed ID: 33949149 [TBL] [Abstract][Full Text] [Related]
7. Unclassifiable CNS tumors in DNA methylation-based classification: clinical challenges and prognostic impact. Drexler R; Brembach F; Sauvigny J; Ricklefs FL; Eckhardt A; Bode H; Gempt J; Lamszus K; Westphal M; Schüller U; Mohme M Acta Neuropathol Commun; 2024 Jan; 12(1):9. PubMed ID: 38229158 [TBL] [Abstract][Full Text] [Related]
8. DistSNE: Distributed computing and online visualization of DNA methylation-based central nervous system tumor classification. Schmid K; Sehring J; Németh A; Harter PN; Weber KJ; Vengadeswaran A; Storf H; Seidemann C; Karki K; Fischer P; Dohmen H; Selignow C; von Deimling A; Grau S; Schröder U; Plate KH; Stein M; Uhl E; Acker T; Amsel D Brain Pathol; 2024 May; 34(3):e13228. PubMed ID: 38012085 [TBL] [Abstract][Full Text] [Related]
9. The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Louis DN; Perry A; Wesseling P; Brat DJ; Cree IA; Figarella-Branger D; Hawkins C; Ng HK; Pfister SM; Reifenberger G; Soffietti R; von Deimling A; Ellison DW Neuro Oncol; 2021 Aug; 23(8):1231-1251. PubMed ID: 34185076 [TBL] [Abstract][Full Text] [Related]
10. Implementation of DNA Methylation Array Profiling in Pediatric Central Nervous System Tumors: The AIM BRAIN Project: An Australian and New Zealand Children's Haematology/Oncology Group Study. White CL; Kinross KM; Moore MK; Rasouli E; Strong R; Jones JM; Cain JE; Sturm D; Sahm F; Jones DTW; Pfister SM; Robertson T; D'Arcy C; Rodriguez ML; Dyke JM; Junckerstorff R; Bhuva DD; Davis MJ; Wood P; Hassall T; Ziegler DS; Kellie S; McCowage G; Alvaro F; Kirby M; Heath JA; Tsui K; Dodgshun A; Eisenstat DD; Khuong-Quang DA; Wall M; Algar EM; Gottardo NG; Hansford JR J Mol Diagn; 2023 Oct; 25(10):709-728. PubMed ID: 37517472 [TBL] [Abstract][Full Text] [Related]
11. Establishing the utility of multi-platform liquid biopsy by integrating the CSF methylome and proteome in CNS tumours. Landry AP; Zuccato JA; Patil V; Voisin MR; Wang JZ; Ellenbogen Y; Gui C; Ajisebutu A; Kislinger T; Nassiri F; Zadeh G J Neurooncol; 2024 Sep; 169(2):233-239. PubMed ID: 39102117 [TBL] [Abstract][Full Text] [Related]
12. DNA methylation-based classification of central nervous system tumours. Capper D; Jones DTW; Sill M; Hovestadt V; Schrimpf D; Sturm D; Koelsche C; Sahm F; Chavez L; Reuss DE; Kratz A; Wefers AK; Huang K; Pajtler KW; Schweizer L; Stichel D; Olar A; Engel NW; Lindenberg K; Harter PN; Braczynski AK; Plate KH; Dohmen H; Garvalov BK; Coras R; Hölsken A; Hewer E; Bewerunge-Hudler M; Schick M; Fischer R; Beschorner R; Schittenhelm J; Staszewski O; Wani K; Varlet P; Pages M; Temming P; Lohmann D; Selt F; Witt H; Milde T; Witt O; Aronica E; Giangaspero F; Rushing E; Scheurlen W; Geisenberger C; Rodriguez FJ; Becker A; Preusser M; Haberler C; Bjerkvig R; Cryan J; Farrell M; Deckert M; Hench J; Frank S; Serrano J; Kannan K; Tsirigos A; Brück W; Hofer S; Brehmer S; Seiz-Rosenhagen M; Hänggi D; Hans V; Rozsnoki S; Hansford JR; Kohlhof P; Kristensen BW; Lechner M; Lopes B; Mawrin C; Ketter R; Kulozik A; Khatib Z; Heppner F; Koch A; Jouvet A; Keohane C; Mühleisen H; Mueller W; Pohl U; Prinz M; Benner A; Zapatka M; Gottardo NG; Driever PH; Kramm CM; Müller HL; Rutkowski S; von Hoff K; Frühwald MC; Gnekow A; Fleischhack G; Tippelt S; Calaminus G; Monoranu CM; Perry A; Jones C; Jacques TS; Radlwimmer B; Gessi M; Pietsch T; Schramm J; Schackert G; Westphal M; Reifenberger G; Wesseling P; Weller M; Collins VP; Blümcke I; Bendszus M; Debus J; Huang A; Jabado N; Northcott PA; Paulus W; Gajjar A; Robinson GW; Taylor MD; Jaunmuktane Z; Ryzhova M; Platten M; Unterberg A; Wick W; Karajannis MA; Mittelbronn M; Acker T; Hartmann C; Aldape K; Schüller U; Buslei R; Lichter P; Kool M; Herold-Mende C; Ellison DW; Hasselblatt M; Snuderl M; Brandner S; Korshunov A; von Deimling A; Pfister SM Nature; 2018 Mar; 555(7697):469-474. PubMed ID: 29539639 [TBL] [Abstract][Full Text] [Related]
13. Sarcoma classification by DNA methylation profiling in clinical everyday life: the Charité experience. Roohani S; Ehret F; Perez E; Capper D; Jarosch A; Flörcken A; Märdian S; Zips D; Kaul D Clin Epigenetics; 2022 Nov; 14(1):149. PubMed ID: 36380356 [TBL] [Abstract][Full Text] [Related]
14. DNA methylation profiling improves routine diagnosis of paediatric central nervous system tumours: A prospective population-based study. Schepke E; Löfgren M; Pietsch T; Olsson Bontell T; Kling T; Wenger A; Ferreyra Vega S; Danielsson A; Dosa S; Holm S; Öberg A; Nyman P; Eliasson-Hofvander M; Sandström PE; Pfister SM; Lannering B; Sabel M; Carén H Neuropathol Appl Neurobiol; 2022 Oct; 48(6):e12838. PubMed ID: 35892159 [TBL] [Abstract][Full Text] [Related]
15. Pediatric Pan-Central Nervous System Tumor Methylome Analyses Reveal Immune-Related LncRNAs. Li Y; Xu S; Xu D; Pan T; Guo J; Gu S; Lin Q; Li X; Li K; Xiang W Front Immunol; 2022; 13():853904. PubMed ID: 35603200 [TBL] [Abstract][Full Text] [Related]
16. DNA methylation-based profiling for paediatric CNS tumour diagnosis and treatment: a population-based study. Pickles JC; Fairchild AR; Stone TJ; Brownlee L; Merve A; Yasin SA; Avery A; Ahmed SW; Ogunbiyi O; Gonzalez Zapata J; Peary AF; Edwards M; Wilkhu L; Dryden C; Ladon D; Kristiansen M; Rowe C; Kurian KM; Nicoll JAR; Mitchell C; Bloom T; Hilton DA; Al-Sarraj S; Doey L; Johns PN; Bridges LR; Chakrabarty A; Ismail A; Rathi N; Syed K; Lammie GA; Limback-Stanic C; Smith C; Torgersen A; Rae F; Hill RM; Clifford SC; Grabovska Y; Williamson D; Clarke M; Jones C; Capper D; Sill M; von Deimling A; Pfister SM; Jones DTW; Hargrave D; Chalker J; Jacques TS Lancet Child Adolesc Health; 2020 Feb; 4(2):121-130. PubMed ID: 31786093 [TBL] [Abstract][Full Text] [Related]
17. Molecular tumor classification using DNA methylome analysis. Sill M; Plass C; Pfister SM; Lipka DB Hum Mol Genet; 2020 Oct; 29(R2):R205-R213. PubMed ID: 32657331 [TBL] [Abstract][Full Text] [Related]
18. Diffuse glioneuronal tumour with oligodendroglioma-like features and nuclear clusters (DGONC) - a molecularly defined glioneuronal CNS tumour class displaying recurrent monosomy 14. Deng MY; Sill M; Sturm D; Stichel D; Witt H; Ecker J; Wittmann A; Schittenhelm J; Ebinger M; Schuhmann MU; Figarella-Branger D; Aronica E; Staszewski O; Preusser M; Haberler C; Lauten M; Schüller U; Hartmann C; Snuderl M; Dunham C; Jabado N; Wesseling P; Deckert M; Keyvani K; Gottardo N; Giangaspero F; von Hoff K; Ellison DW; Pietsch T; Herold-Mende C; Milde T; Witt O; Kool M; Korshunov A; Wick W; von Deimling A; Pfister SM; Jones DTW; Sahm F Neuropathol Appl Neurobiol; 2020 Aug; 46(5):422-430. PubMed ID: 31867747 [TBL] [Abstract][Full Text] [Related]
19. Cerebrospinal fluid methylome-based liquid biopsies for accurate malignant brain neoplasm classification. Zuccato JA; Patil V; Mansouri S; Voisin M; Chakravarthy A; Shen SY; Nassiri F; Mikolajewicz N; Trifoi M; Skakodub A; Zacharia B; Glantz M; De Carvalho DD; Mansouri A; Zadeh G Neuro Oncol; 2023 Aug; 25(8):1452-1460. PubMed ID: 36455236 [TBL] [Abstract][Full Text] [Related]
20. Overview of recent advances in the classification of ependymomas in WHO CNS5 classification: Simplified approach to their integrated diagnosis. Gupta RK; Sharma A; Sharma MC Indian J Pathol Microbiol; 2022 May; 65(Supplement):S68-S72. PubMed ID: 35562136 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]